Regenxbio (RGNX) Amortizatization of Intangibles (2015 - 2025)
Regenxbio's (RGNX) quarterly Amortizatization of Intangibles came in at $1.2 million in Q4 2025, up 10.03% year-on-year from $1.1 million in Q4 2024, and down 32.58% quarter-over-quarter from $1.8 million in Q3 2025.
Regenxbio (RGNX) Amortizatization of Intangibles (2015 - 2025) Analysis & Trends
Regenxbio's Amortizatization of Intangibles history runs 11 years deep, the most recent figure standing at $1.2 million for Q4 2025.
- On a quarterly basis, Amortizatization of Intangibles rose 10.03% year-over-year to $1.2 million in Q4 2025; TTM through Dec 2025 was $5.5 million, a 32.22% increase from a year earlier, with the FY2025 full-year figure at $5.5 million, up 32.22% from the prior year.
- Amortizatization of Intangibles retreated to $1.2 million in Q4 2025 per RGNX's latest filing, from $1.8 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.8 million in Q3 2025 and bottomed at -$1.6 million in Q2 2021.
- The 5-year median for Amortizatization of Intangibles is -$123500.0 (2023), against an average of -$80900.0.
- Across the five-year window, Amortizatization of Intangibles slumped 3202.56% in 2021 and soared 889.47% in 2024, its largest moves.
- Year by year, Amortizatization of Intangibles stood at -$1.5 million in 2021, then soared by 38.36% to -$903000.0 in 2022, then jumped by 126.8% to $242000.0 in 2023, then surged by 361.57% to $1.1 million in 2024, then climbed by 10.03% to $1.2 million in 2025.
- Per Business Quant, the three latest RGNX Amortizatization of Intangibles figures stand at $1.2 million (Q4 2025), $1.8 million (Q3 2025), and $1.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Regenxbio | 501.81 Mn | 271.74 Mn | 21.22 Mn | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.23 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | 468,000.00 |
| Mar 31, 2024 | 468,000.00 |
| Dec 31, 2023 | 242,000.00 |
| Dec 31, 2023 | 242,000.00 |
| Sep 30, 2023 | 133,000.00 |
| Sep 30, 2023 | 133,000.00 |